Drug intelligence / Profile preview

Longshen Tonic Ointment

Development stage: Unknown
Lead developer: Jiangsu Pharmaceutical
Administration: Topical

Overview

Longshen Tonic Ointment is a traditional Chinese medicine (TCM) topical formulation developed and manufactured by Jiangsu Pharmaceutical, a subsidiary of the Yangtze River Pharmaceutical Group. It is indicated for the treatment of fatigue and dizziness. Based on TCM therapeutic principles, the ointment is designed to nourish qi and blood while supporting liver and kidney function. The product is currently approved and marketed in China as a topical treatment for symptoms associated with qi and blood deficiency.

Brand names: Longshen Tonic Ointment
Other names: Longshen Tonic

Beyond the preview

Go deeper on Longshen Tonic Ointment.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Longshen Tonic Ointment.

Explore the full profile